G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3) Peptide
G2E3
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN978925
Aperçu rapide pour G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3) Peptide (ABIN978925)
Antigène
G2E3
(G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-KIAA1333 antibody (Catalog #: ARP43228_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
G2E3
(G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3))
Sujet
KIAA1333 is a probable E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates.